All 60 CANC (TEMA ONCOLOGY ETF) Holdings
There are 60 CANC holdings. Top 10 companies weight: 40.15%.
Total Market Cap: $3.19T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (60 stocks) | +16.24% | 31.61 | 22.14 | 0.39 | +11.40% | +21.41% | 0.55 | ||||||||||
1 | RVMD | Revolution Medicines Inc Ordinary Shares | 6.05% | $180.39 | $37B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +11.15% | $201 | +42.94% | 1.09 |
2 | LLY | Eli Lilly And Co | 4.93% | $1,146.37 | $1.03T | Drug Manufacturers - General | Healthcare | +29.14% | 48.44 | 33.67 | 0.19 | N/A | N/A | 71 | +10.82% | $1.27K | +38.32% | 0.65 |
3 | COGT | Cogent Biosciences Inc | 4.92% | $38.30 | $6.71B | Biotechnology | Healthcare | -15.32% | N/A | N/A | N/A | N/A | N/A | 75 | +41.64% | $54 | +40.97% | 1.71 |
4 | n/a | Novartis Ag Registered Shares | 4.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
5 | RHHBY | Roche Holding Ag Adr | 3.76% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
6 | MRK | Merck & Co Inc | 3.39% | $124.40 | $292B | Drug Manufacturers - General | Healthcare | +5.37% | 26.93 | 47.17 | 6.13 | N/A | N/A | 68 | +7.75% | $134 | +13.73% | 0.29 |
7 | JNJ | Johnson & Johnson | 3.34% | $248.94 | $595B | Drug Manufacturers - General | Healthcare | +11.59% | 22.09 | 21.74 | 4.95 | N/A | N/A | 70 | +8.44% | $270 | +11.07% | N/A |
8 | LEGN | Legend Biotech Corp Adr | 3.27% | $23.21 | $4.26B | Biotechnology | Healthcare | -13.49% | N/A | 149.25 | N/A | N/A | N/A | 80 | +139.68% | $56 | -13.38% | 0.49 |
9 | BMY | Bristol-myers Squibb Co | 3.25% | $60.18 | $120B | Drug Manufacturers - General | Healthcare | +5.08% | 13.82 | 9.59 | 1.54 | N/A | N/A | N/A | N/A | N/A | +1.92% | N/A |
10 | ABBV | Abbvie Inc | 3.23% | $253.44 | $432B | Drug Manufacturers - General | Healthcare | -19.65% | 139.08 | 18.02 | 0.40 | N/A | N/A | 74 | +5.18% | $267 | +21.10% | 0.28 |
11 | IMNM | Immunome Inc Ordinary Shares | 3.21% | $22.16 | $2.59B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +61.42% | $36 | +4.86% | 1.64 |
12 | EXEL | Exelixis Inc | 2.86% | $55.53 | $14B | Biotechnology | Healthcare | +72.24% | 17.54 | 17.70 | 0.45 | N/A | N/A | 59 | -8.28% | $51 | +26.67% | 0.52 |
13 | AZN:XLON | Astrazeneca Plc | 2.72% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
14 | IDYA | Ideaya Biosciences Inc | 2.63% | $35.45 | $3.23B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +47.50% | $52 | +10.45% | 1.10 |
15 | CGON | Cg Oncology Inc | 2.61% | $70.19 | $6.42B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +28.64% | $90 | 0.00% | 1.46 |
16 | BBIO | Bridgebio Pharma Inc | 2.59% | $80.76 | $16B | Biotechnology | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 79 | +29.74% | $105 | +5.57% | 1.02 |
17 | AMGN | Amgen Inc | 2.53% | $364.17 | $193B | Drug Manufacturers - General | Healthcare | +3.49% | 24.75 | 16.47 | 0.79 | N/A | N/A | 60 | -2.07% | $357 | +11.73% | 0.46 |
18 | GMAB | Genmab As Adr | 2.42% | $27.91 | $19B | Biotechnology | Healthcare | -30.81% | 140.29 | 16.95 | 1.91 | N/A | N/A | 70 | +32.28% | $37 | -8.76% | 0.59 |
19 | CELC | Celcuity Inc | 2.40% | $87.99 | $4.42B | Biotechnology | Healthcare | +36.83% | N/A | N/A | N/A | N/A | N/A | 79 | +85.76% | $163 | +32.62% | 1.07 |
20 | FXFXX | First American Treasury Obligs X | 1.91% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
21 | ERAS | Erasca Inc | 1.88% | $18.82 | $5.51B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +21.15% | $23 | -1.13% | 1.37 |
22 | ONC | Beone Medicines Ltd Adr | 1.86% | $310.58 | $36B | Biotechnology | Healthcare | N/A | 69.54 | 47.39 | N/A | N/A | N/A | 81 | +33.57% | $415 | +0.26% | 0.54 |
23 | RLAY | Relay Therapeutics Inc Ordinary Shares | 1.78% | $19.18 | $3.69B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +32.33% | $25 | -11.08% | 1.84 |
24 | HALO | Halozyme Therapeutics Inc | 1.68% | $77.09 | $8.99B | Biotechnology | Healthcare | +20.06% | 25.62 | 10.78 | N/A | N/A | N/A | 67 | +8.83% | $84 | +12.87% | 0.62 |
25 | ELVN | Enliven Therapeutics Inc | 1.66% | $51.67 | $3.24B | Biotechnology | Healthcare | -7.13% | N/A | N/A | N/A | N/A | N/A | 75 | +27.73% | $66 | +17.53% | 1.16 |
26 | ZLAB | Zai Lab Ltd Adr Repr 1 Shs | 1.57% | $20.52 | $2.27B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +62.28% | $33 | -33.36% | 0.91 |
27 | ZYME | Zymeworks Inc Registered Shs | 1.38% | $23.76 | $1.80B | Biotechnology | Healthcare | N/A | N/A | 24.21 | N/A | N/A | N/A | 79 | +65.53% | $39 | -8.46% | 0.83 |
28 | RCUS | Arcus Biosciences Inc | 1.25% | $28.17 | $3.52B | Biotechnology | Healthcare | +14.36% | N/A | N/A | N/A | N/A | N/A | 68 | +26.91% | $36 | -2.35% | 1.50 |
29 | NUVB | Nuvation Bio Inc Ordinary Shares Class A | 1.23% | $6.26 | $2.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +96.96% | $12 | -6.73% | 1.47 |
30 | URGN | Urogen Pharma Ltd | 1.21% | $41.12 | $1.94B | Biotechnology | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 75 | +1.22% | $42 | +20.85% | 1.18 |
31 | CRVS | Corvus Pharmaceuticals Inc | 1.08% | $14.10 | $1.25B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | 78 | +136.38% | $33 | +43.22% | 0.75 |
32 | TYRA | Tyra Biosciences Inc | 1.06% | $31.06 | $1.93B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +67.35% | $52 | 0.00% | 1.01 |
33 | ANAB | Anaptysbio Inc | 1.03% | $50.29 | $1.62B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 81 | +73.18% | $87 | +23.70% | 0.80 |
34 | GILD | Gilead Sciences Inc | 1.01% | $133.21 | $164B | Drug Manufacturers - General | Healthcare | +98.59% | 17.75 | 15.22 | 0.32 | N/A | N/A | 74 | +18.83% | $158 | +18.49% | 0.35 |
35 | SMMT | Summit Therapeutics Inc Ordinary Shares | 0.99% | $13.50 | $12B | Biotechnology | Healthcare | N/A | N/A | 3.72 | N/A | N/A | N/A | 60 | +113.33% | $29 | +12.03% | 1.75 |
36 | KURA | Kura Oncology Inc | 0.97% | $10.68 | $1.01B | Biotechnology | Healthcare | +15.40% | N/A | N/A | N/A | N/A | N/A | 76 | +191.85% | $31 | -10.92% | 1.06 |
37 | GH | Guardant Health Inc | 0.93% | $148.07 | $21B | Diagnostics & Research | Healthcare | +1.05% | N/A | N/A | N/A | N/A | N/A | 77 | +15.54% | $171 | +4.43% | 1.17 |
38 | SNDX | Syndax Pharmaceuticals Inc | 0.92% | $22.29 | $2.08B | Biotechnology | Healthcare | +12.13% | N/A | N/A | N/A | N/A | N/A | 78 | +74.97% | $39 | +7.89% | 1.03 |
39 | TNGX | Tango Therapeutics Inc | 0.87% | $27.54 | $4.36B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +60.97% | $44 | +21.35% | 1.39 |
40 | IMTX | Immatics Nv Ordinary Shares | 0.85% | $9.23 | $1.28B | Biotechnology | Healthcare | -15.05% | N/A | N/A | N/A | N/A | N/A | 75 | +104.66% | $19 | -5.40% | 1.29 |
41 | AVBP | Arrivent Biopharma Inc | 0.79% | $28.22 | $1.49B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +54.64% | $44 | 0.00% | 0.94 |
42 | IMCR | Immunocore Holdings Plc Adr | 0.76% | $34.05 | $1.76B | Biotechnology | Healthcare | N/A | N/A | 232.56 | N/A | N/A | N/A | 69 | +86.11% | $63 | -0.94% | 0.70 |
43 | REGN | Regeneron Pharmaceuticals Inc | 0.74% | $672.15 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.87% | $819 | +3.03% | 0.60 |
44 | NTRA | Natera Inc | 0.61% | $262.63 | $40B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +7.43% | $282 | +17.53% | 1.29 |
45 | CGEM | Cullinan Therapeutics Inc | 0.59% | $17.50 | $1.10B | Biotechnology | Healthcare | N/A | N/A | 6.74 | N/A | N/A | N/A | 77 | +80.29% | $32 | -8.28% | 1.05 |
46 | IOVA | Iovance Biotherapeutics Inc | 0.58% | $5.02 | $2.08B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +75.30% | $8.80 | -26.70% | 1.59 |
47 | n/a | Chugai Pharmaceutical Co Ltd | 0.56% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
48 | TRAX | First Tracks Biotherapeutics Inc | 0.56% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
49 | INBX | Inhibrx Biosciences Inc | 0.50% | $84.09 | $1.33B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +230.00% | $278 | 0.00% | 1.39 |
50 | OLMA | Olema Pharmaceuticals Inc Ordinary Shares | 0.50% | $11.35 | $1.03B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +258.59% | $41 | -15.44% | 0.72 |
CANC (TEMA ONCOLOGY ETF) Sector Allocation
HEALTHCARE
83.10%MATERIALS
2.70%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%